News

The physician Matthias Tschöp is one of the leading international scientists in the field of diabetes and obesity. He is responsible for a number of discoveries, most notably the new obesity drugs. Developing an effective therapy for obesity has been his focus since the beginning of his career. Tschöp has now given a lecture to the German National Academy of Sciences Leopoldina on the subject of “The new weight loss injection - from development to application”.

[Translate to Englisch:] Prof. Tschöp am Rednerpult der Leopoldina. — Prof. Dr. Matthias Tschöp addressing the Leopoldina. © Screenshot video of the lecture from 11.07.2024 in Halle

Prof. Matthias Tschöp, Scientific CEO of Helmholtz Munich, is a member of the Leopoldina. On July 11, he spoke in Halle about the beginnings of his research up to today's application; the scientific findings that laid the foundations for the studies on hormones, signal communication between the gastrointestinal tract and the brain, which led him to discover the new class of active substances known as polyagonists together with chemist Richard DiMarchi. These can effectively treat obesity and have an impact on the global obesity pandemic.

The German National Academy of Sciences Leopoldina brings together the expertise of some 1,600 distinguished scientists to bear on questions of social and political relevance, publishing unbiased and timely scientific opinions. The Leopoldina represents the German scientific community in international committees and promotes a scientifically enlightened society.

Link to the video (in German)

Back

Leopoldina Lecture on the “weight loss injection” by DZD Scientist Matthias Tschöp